Malaria Parasite Protein Shows Promise as Cancer TherapeuticNews
A drug created from a malaria protein stopped tumour growth of chemotherapy-resistant bladder cancer, offering hope for cancer patients not responding to standard treatments.Read more
The Next Generation of Pancreatic Cancer TherapeuticsNews
Currently, there are not many effective therapies available other than surgery, and that is not an option for many patients.Read more
Agilent Technologies Presents Thought Leader Award to Professor Dwight Stoll for Separation Science ResearchNews
Prof. Stoll receives the award in support of his research, applying two-dimensional liquid chromatography (2D-LC) to biopharmaceutical analysis.
Quality Requirements for Biotech Products from First-In-Human to Phase III
Apr 26 - Apr 28, 2017